Argus analyst David Toung downgraded Catalent to Sell from Buy in light of the pending merger between Catalent and Novo Holdings. The firm will be dropping coverage of Catalent and will remove the stock from its universe of coverage in the next 30 days, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTLT: